SAN FRANCISCO--(BUSINESS WIRE)--
Invitae
Corporation (NYSE:NVTA)
today announced that members of the company’s management team will
present at the 2015 Morgan Stanley Global Healthcare Conference on
Friday, September 18, 2015 at approximately 8:45 a.m. Eastern / 5:45
a.m. Pacific in New York City.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20150910005443/en/
The live, listen-only webcast of the presentation may be accessed by
visiting the Investors section of the company’s website at ir.invitae.com.
A replay of the webcasts will be available shortly after the conclusion
of the presentation and will be archived on the company’s website.
About Invitae
Invitae’s (NYSE: NVTA) mission is to bring comprehensive genetic
information into mainstream medical practice to improve the quality of
healthcare for billions of people. Invitae’s goal is to aggregate most
of the world’s genetic tests into a single service with higher quality,
faster turnaround time and lower price than many single-gene tests
today. The company currently provides a single diagnostic service
comprising more than 200 genes for a variety of genetic disorders
associated with oncology, cardiology, neurology, pediatrics, hematology,
and other disease areas.
For more information, visit our website at ir.invitae.com
and follow us on Twitter: @invitae
and @invitaeIR.
Source: Invitae Corporation

View source version on businesswire.com: http://www.businesswire.com/news/home/20150910005443/en/
Source: Invitae Corporation